Human Molecular GeneticsPathologyPeer-reviewed journal article
BIN1 overexpression rescues cardiac but not skeletal muscle defects in a mouse model of caveolinopathy
Alice MoncheauxiD, Alain Guimond, Coralie SpiegelhalteriD, Nadia MessaddeqiD, Chadia Nahy, Jocelyn LaporteiD
Abstract
BackgroundMutations in CAV3, encoding caveolin-3, cause caveolinopathies, rare genetic disorders affecting both skeletal and cardiac muscle. Caveolin-3 contributes to T-tubule formation and excitation-contraction coupling. BIN1 (amphiphysin 2), a membrane-shaping protein critical for T-tubule integrity, has shown therapeutic promise in congenital myopathies and heart dysfunction. To date, there are no therapy for caveolinopathies. MethodsWe evaluated the therapeutic impact of BIN1 overexpression in Cav-3 knockout mice, a model recapitulating key features of human caveolinopathy. We assessed skeletal and cardiac function, T-tubule morphology, mitochondria, and gene expression using histological, physiological, and molecular approaches. ResultsWe found Cav-3-/- mice displayed skeletal muscle weakness, T-tubule disorganization, and mitochondrial abnormalities, alongside cardiac diastolic dysfunction and myofibrillar disarray. While BIN1 overexpression failed to improve skeletal muscle strength, T-tubule structure, or fiber atrophy, it corrected nuclear positioning and partially restored mitochondrial markers. In contrast, BIN1 robustly rescued cardiac performance, restoring end-diastolic volume, cardiac output, and sarcomeric integrity. Expression profiling revealed greater dysregulation of excitation-contraction coupling and atrogene pathways in skeletal than in cardiac muscle. Cavin-4, a BIN1-interacting protein, was selectively dysregulated in Cav3-/- muscle, suggesting a mechanistic barrier to BIN1-mediated rescue in this tissue. ConclusionsThese findings identify tissue-specific differences in the molecular consequences of caveolin-3 loss and demonstrate that BIN1 overexpression effectively rescues cardiac, but not skeletal, manifestations of caveolinopathy. Our results support BIN1 as a promising gene therapy target for inherited cardiomyopathies, while highlighting the need for alternative strategies in skeletal muscle.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 1th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lack of functional caveolae in Cav3 mutated human dystrophic myotubes results in deficient mechanoprotection and IL6/STAT3 mechanosignaling.
Melissa Dewulf, Darius Köster, … Cedric M. Blouin·bioRxiv·Mar 20, 2018
- Caveolae and Bin1 form ring-shaped platforms for T-tubule initiation
E. Lemerle, J. Laine, … S. Vassilopoulos·bioRxiv·Nov 1, 2022
- Cardiomyocyte caveolae govern myocardial function and sex-dependent regulation of ventricular compliance and resilience via cavin-1
Benjamin T Quick, H. Khoo, … Melissa E. Reichelt·bioRxiv·Apr 21, 2026
- Muscle-specific Cavin4 interacts with Bin1 to promote T-tubule formation and stability in developing skeletal muscle
- Loss of calpain 3 dysregulates store-operated calcium entry and its exercise response in mice
K. R. Villani, R. Zhong, … L. Wei-LaPierre·bioRxiv·Jan 12, 2024
- Loss of Caveolin-1 and caveolae leads to increased cardiac cell stiffness and functional decline of the adult zebrafish heart
Dimitrios Grivas, Álvaro González-Rajal, … José Luís de la Pompa·Scientific ReportsPeer-reviewed·Jul 30, 2020